Skip to main content
. 2015 Jul 27;33(25):2772–2779. doi: 10.1200/JCO.2015.60.8133

Table 1.

Demographic, Disease, and Treatment Characteristics According to Histologic Subtype

Characteristic Histologic Subtype (N = 2,923)
Fisher's Exact P
Ductal (n = 2,599)
Lobular (n = 324)
No. % No. %
Chemotherapy strata .01
    No chemotherapy 2,059 79.2 237 73.1
    Received chemotherapy 540 20.8 87 26.9
Random assignment strata .001
    4-arm 1,880 72.3 262 80.9
    2-arm 719 27.7 62 19.1
Subtype < .001
    Lum A 1,436 55.3 237 73.1
    Lum B 1,163 44.7 87 26.9
Age, years .19
    ≤ 55 584 22.5 86 26.5
    56-70 1,638 63.0 199 61.4
    ≥ 71 377 14.5 39 12.0
Obese (BMI ≥ 30 kg/m2) .93
    No 1,929 74.2 243 75.0
    Yes 561 21.6 67 20.7
    Unknown 109 4.2 14 4.3
Nodal status .29
    Nx/N0 1,473 56.7 178 54.9
    N1-N3 709 27.3 83 25.6
    ≥ N4 417 16.0 63 19.4
Tumor size, cm < .001
    < 2 1,685 64.8 158 48.8
    ≥ 2 905 34.8 162 50.0
    Missing 9 0.3 4 1.2
Tumor grade (centrally assessed) < .001
    1 553 21.3 13 4.0
    2 1,443 55.5 309 95.4
    3 589 22.7 2 0.6
    Missing 14 0.5
Peritumoral invasion (centrally assessed) < .001
    No 2,304 88.6 317 97.8
    Yes 285 11.0 7 2.2
    Missing 10 0.4
Treatment assigned .32
    Letrozole 1,300 50.0 152 46.9
    Tamoxifen 1,299 50.0 172 53.1
Local therapy < .001
    LTM/RT 1,426 54.9 145 44.8
    LTM/no RT 85 3.3 4 1.2
    Mastectomy/RT 423 16.3 86 26.5
    Mastectomy/no RT 663 25.5 88 27.2
    Other 2 0.1 1 0.3

Abbreviations: BMI, body mass index; LTM: less than mastectomy; Lum A, luminal A; Lum B, luminal B; RT, radiotherapy.